Clinical Site Reactivation Amid COVID-19: Site Suggestions for Sponsors
In May 2020, Syneos Health hosted a panel discussion and Q&A session with three US Principal Investigators. Together, we discussed considerations for clinical trial sites as they continue ongoing activities & plan to restart trials in light of the COVID-19 pandemic.
In this video, Clare Grace relays our learnings for sponsors, including:
- Silver linings and long-term considerations
- Who to consult for advice – beyond Principal Investigators
- Tips for streamlining new processes
- Impact of personalized communications and a humanized approach
This video is part of a two-part series on Clinical Site Reactivation, highlighting the clinical sites’ experience with patient interactions and offering suggestions for sponsors.
The Clinical Site Reactivation series is part of Syneos Health Insights Hub Live. Syneos Health Insights Hub Live uncovers unique insights and global trends discovered by experts working on the front lines of healthcare around the world. How do we change lives? Watch and learn.
Next Article in the Series
Looking for exclusive insight?
